Genomics

Explore our range of solutions, from comprehensive to off-the-shelf, to accelerate your molecular biology research.

Western Blots

Check out our Western Blotting Protocol or browse our entire catalogue of Western Blot Literature & Resources to help guide you.

Materials Science

Browse innovative materials science products for your specific research areas.

Analytical

Explore our complete range of high-quality products for accurate, brilliant results in a variety of analytical applications.

Communication Updates

Check out the latest communication updates.

Join our Mailing List

Receive your choice of the newsletters, promotions, and more.

Education & Learning

Tune-in to our live and on-demand webinar and video libraries to learn advanced research techniques.

Meet Our Team

Our team is here for you. Reach out, connect with us, ask us questions, and let's make great things happen!

Contact Us

Phone: 0800 936 666
Email: anzcs@merckgroup.com

News & Information

Singapore - September 15, 2020 Merck KGaA, Darmstadt, Germany Expands BioReliance® Viral Clearance Offering in Singapore, Saving Customers Time

Merck KGaA, Darmstadt, Germany today announced an expansion of its Singapore biosafety testing laboratory services.

Read More
Darmstadt, Germany - September 9, 2020 Merck KGaA, Darmstadt, Germany Announces € 59 Million Antibody-Drug Conjugate Manufacturing Expansion

Merck KGaA, Darmstadt, Germany today announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA.

Read More
Jakarta, Indonesia - September 3, 2020 Merck KGaA, Darmstadt, Germany Supports Eijkman Institute to Expedite Covid-19 Vaccine Development Research

Merck KGaA, Darmstadt, Germany today announced the donation of research instruments and materials worth IDR 1.2 billion (€ 74,000) to support the efforts of Eijkman Institute for Molecular Biology, Indonesia, in its efforts to accelerate vaccine development research. The institute is developing a Covid-19 vaccine based on a local virus strain, in collaboration with several local research institutions.

Read More